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February 14, 2012:699–701respectively. An age-extrapolated CIMT value of 0.51 mm was
found in the Atherosclerosis Risk in Communities study investi-
gating 40- to 60-year-old subjects (6). The Cardiovascular Risk in
Young Finns Study of slightly older men than our NFL group (24
to 39 years of age) revealed a mean CIMT of 0.64 mm (7). In this
study, CIMT was significantly correlated with body mass index,
systolic blood pressure, low-density lipoprotein levels, and smok-
ing. The Bogalusa Heart Study, also of older subjects (25 to 39
years of age), found mean CIMT to be 0.67 mm in whites and 0.71
mm in blacks (8). Although the CIMT value we found in the NFL
populations was near the higher end of the published range, precise
comparison was not possible.
There are several limitations to our study. The study cohort may be
too small to adequately identify all correlates of CIMT. It would be
most helpful to have a comparison population better matched for age
and cardiovascular risk factors. It would be beneficial to obtain
measurements at more than one time during and after their career.
In active NFL players, CIMT correlates with some parameters of
size (body mass index, weight, and waist circumference) but not with
other traditional cardiovascular risk factors. CIMT values from studies
most similar in age were found to be generally lower than our
population. A possible link between large body size and cardiovascular
risk may exist independent of traditional risk factors.
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Study. J Am Coll Cardiol 2005;46:457–63.Letters to the EditorCoronary Computed Tomography
Angiography Versus Coronary
Calcium Computed Tomography for
Prognosis With Regard to Mortality
Min et al. (1) present important information on a large database of
individuals undergoing coronary computed tomography angiogra-
phy (CCTA) with regard to the significance of coronary stenosis as
a predictor of future mortality. This study demonstrates the
prognostic significance of coronary stenosis as assessed by CCTA
in predicting future mortality.
There is another important question that this data set has the potential
to answer. Does the number of vessels with significant coronary stenosis
present have prognostic significance in terms ofmortality beyond a simple
measure of total coronary artery plaque as assessed by coronary arteryA key question for any diagnostic tool to be added to the
armamentarium of available tests for the purpose of assessing
mortality is whether the new test performs better than less
expensive test modalities, particularly if there is a less expensive
diagnostic test with slightly less risk.
Coronary calcium CT is much less expensive and uses approx-
imately one-tenth of the radiation of CCTA (2). It is important
therefore to demonstrate an improvement over this less-costly
modality, which imparts considerably less radiation, when the goal
is to predict prognosis regarding mortality.
Would the authors re-examine their data for stratification of
these same patients according to coronary calcium results with
regard to mortality prognosis? Because CCTA, in many cases, is
performed with a coronary calcium CT at the onset of the test, this
information is potentially available.
In the dataset of the paper, 42.5% of the patients were
normal, 34.0% were found to have nonobstructive coronary
artery disease (CAD), 13.1% had 1-vessel CAD, and 10.4%
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February 14, 2012:699–701were found to have either 2- or 3-vessel CAD when assessed by
using CCTA.
Using scores from the screening coronary calcium CT scan, the
patients can similarly be divided into the 10% with the highest
absolute coronary calcium scores, the 13% of the patients with the
next highest scores, followed by the next 34% of the patients, and
finally the remaining approximately 43% of patients with no
calcium present (or very low calcium scores).
The same Kaplan-Meier analysis can then be applied to these
groups separated on the basis of their absolute coronary calcium
score (assuming that score is available). If these groups, when
separated on the basis of the calcium scores, stratify mortality
outcomes as well as the CCTA results for the number of vessels
with coronary stenosis, this would be useful information.
A much less expensive test that imparts considerably less
radiation can then be used to help assess future mortality. In
addition, regardless of the result, this would represent additional
information regarding how much coronary artery stenosis plays a
role in mortality prognosis beyond total coronary plaque burden.
*Eric Roehm, MD
*7507 Parkview Circle
Austin, Texas 78731
E-mail: ericfr3@gmail.com
doi:10.1016/j.jacc.2011.09.068
EFERENCES
1. Min JK, Dunning A, Lin FY, et al. Age and sex-related differences in
all-cause mortality risk based on coronary computed tomography
angiography findings. J Am Coll Cardiol 2011;58:849–60.
2. Conti CR. Cardiovascular studies and the radiation dose. Clin Cardiol
2009;32:56–7.
Reply
We thank Dr. Roehm for his comments addressing our findings
from the CONFIRM registry (1). He questioned whether the
prognostic value of coronary artery disease stenosis severity by
using coronary computed tomography angiography (CCTA) is
additive to findings provided by noncontrast coronary artery
calcium scoring (CACS). This distinction is of high importance
and relates to whether stenosis or plaque detection is most germane
for clinical risk prediction.
Previous population studies have demonstrated significant im-
provement in risk stratification by CACS beyond clinical risk factors,
and CACS is now considered reasonable for asymptomatic adults at
10% to 20% 10-year risk of events (2,3). In contrast, CCTA has
generally been used for symptomatic individuals for detection or
exclusion of coronary stenosis, and current American College of
Cardiology Foundation Appropriate Use Criteria are in keeping with
this practice (4). CCTA is safe, with significant improvements in
echnology now allowing performance with radiation doses similar to
ACS (5). To date, the differential prognostic utility of CCTA
tenosis and CACS has been inadequately explored.
One additional benefit of CCTA is its ability to assess other
therosclerotic plaque characteristics (APCs). Recent CCTA stud-
es have examined plaque features that are only visualized by
ontrast enhancement and include low attenuation plaque, positive
rterial remodeling, and admixtures of noncalcified and calcified
laque (6,7). These investigations have denoted a prognosticimportance for APCs, both for myocardial ischemia and acute
coronary syndromes. Although quantitative assessment of APCs is
currently time-intensive, novel validated software now offers an
automated method for comprehensive characterization of stenosis,
calcified plaque, and other APCs (8).
Evaluation of the incremental significance of CCTA findings is
vital and should entail not only descriptions of calcified plaque but
also the entirety of APCs important to coronary events. This
evaluation within the CONFIRM registry is ongoing.
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